Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial
Patrick Most1, Hanna Seifert, Erhe Gao
1Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA. patrick.most@jefferson.edu
Insights
Reduced S100A1 protein in the heart worsens heart failure after myocardial infarction. Increasing S100A1 levels protects cardiac function and improves survival in heart failure models.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Diminished S100A1 protein is observed in human cardiomyopathies.
- S100A1 is a calcium-dependent inotropic factor in the heart.
Purpose of the Study:
- To investigate the role of S100A1 protein levels in the development and progression of post-ischemic heart failure (HF).
Main Methods:
- S100A1-transgenic (STG) and S100A1-knockout (SKO) mice underwent myocardial infarction (MI).
- Cardiac function, remodeling, apoptosis, and survival were compared between STG, SKO, nontransgenic littermate control (NLC), and wild-type (WT) mice up to 4 weeks post-MI.
Main Results:
- S100A1-deficient hearts (SKO-MI) showed acute contractile decompensation, accelerated HF progression, increased apoptosis, and higher mortality.
- S100A1-overexpressing hearts (STG-MI) demonstrated preserved cardiac function, reduced apoptosis, and prevention of hypertrophy and HF, with superior survival.
- Signaling pathways (Gq, Gs, PKC) influenced cardiac S100A1 levels, impacting sarcoplasmic reticulum Ca2+ cycling and beta-adrenergic signaling.
Conclusions:
- Downregulation of S100A1 protein critically contributes to cardiac contractile dysfunction in heart failure.
- S100A1 levels are a key determinant of the clinical course in patients with heart failure.
Background:
Diminished cardiac S100A1 protein levels are characteristic of ischemic and dilated human cardiomyopathy. Because S100A1 has recently been identified as a Ca2+-dependent inotropic factor in the heart, this study sought to explore the pathophysiological relevance of S100A1 levels in development and progression of postischemic heart failure (HF).
Methods And Results:
S100A1-transgenic (STG) and S100A1-knockout (SKO) mice were subjected to myocardial infarction (MI) by surgical left anterior descending coronary artery ligation, and survival, cardiac function, and remodeling were compared with nontransgenic littermate control (NLC) and wild-type (WT) animals up to 4 weeks. Although MI size was similar in all groups, infarcted S100A1-deficient hearts (SKO-MI) responded with acute contractile decompensation and accelerated transition to HF, rapid onset of cardiac remodeling with augmented apoptosis, and excessive mortality. NLC/WT-MI mice, displaying a progressive decrease in cardiac S100A1 expression, showed a later onset of cardiac remodeling and progression to HF. Infarcted S100A1-overexpressing hearts (STG-MI), however, showed preserved global contractile performance, abrogated apoptosis, and prevention from cardiac hypertrophy and HF with superior survival compared with NLC/WT-MI and SKO-MI. Both Gq-protein-dependent signaling and protein kinase C activation resulted in decreased cardiac S100A1 mRNA and protein levels, whereas Gs-protein-related signaling exerted opposite effects on cardiac S100A1 abundance. Mechanistically, sarcoplasmic reticulum Ca2+ cycling and beta-adrenergic signaling were severely impaired in SKO-MI myocardium but preserved in STG-MI.
Conclusions:
Our novel proof-of-concept study provides evidence that downregulation of S100A1 protein critically contributes to contractile dysfunction of the diseased heart, which is potentially responsible for driving the progressive downhill clinical course of patients with HF.
Related Concept Videos
Pathophysiology of Cardiac Performance
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy


